表紙:世界のワクチンアジュバント市場:製品タイプ別(粒子、エマルジョン、病原体、サポニン)、投与ルート別(皮下、筋肉内)、疾患タイプ別(感染性、癌)、用途別(研究、商業)、地域別予測(2021~2027年)
市場調査レポート
商品コード
1019258

世界のワクチンアジュバント市場:製品タイプ別(粒子、エマルジョン、病原体、サポニン)、投与ルート別(皮下、筋肉内)、疾患タイプ別(感染性、癌)、用途別(研究、商業)、地域別予測(2021~2027年)

Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
世界のワクチンアジュバント市場:製品タイプ別(粒子、エマルジョン、病原体、サポニン)、投与ルート別(皮下、筋肉内)、疾患タイプ別(感染性、癌)、用途別(研究、商業)、地域別予測(2021~2027年)
出版日: 2021年07月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のワクチンアジュバントの市場規模は2020年に約7億米ドルとなりました。

同市場は、2021年から2027年の予測期間にわたって10.5%を超える健全な成長率で成長すると予想されています。

ワクチンアジュバントは、他の薬剤の効果の変更を助ける免疫剤です。免疫応答を高め、抗原に対する長期的な保護を提供するためにワクチン接種に含まれています。ワクチンにアジュバントを添加して、ワクチン接種に対する体の反応を改善すると同時に、患者に投与するワクチンの投与回数を減らします。水酸化アルミニウムとパラフィンオイルは、最も頻繁に使用されるアジュバントです。ワクチンアジュバントはまた、投与される異物の量を減らします。また、研究や商業目的で使用されています。

市場の成長は、感染症や人獣共通感染症の有病率が高く、さまざまな政府機関からの免疫化プログラムへの注目が高まっていることによって推進されています。たとえば、世界中のさまざまな政府機関が、炭疽病、BCG、肝炎、HPV、インフルエンザ、水痘、天然痘、その他の病気などの病気に対するワクチン接種を促進し、意識を高めています。米国政府は、2019年にワクチンと免疫化のための世界のアライアンス(GAVI、現在はGAVI、ワクチンアライアンスとして知られています)に2億9千万米ドル、他の国での小児ワクチンキャンペーンを支援するために保健福祉省(HHS)に2億2,600万米ドルを提供しました。ただし、厳格な規制環境と承認にかかる時間の長さが、2021年から2027年の予測期間にわたって市場の成長を妨げるとみられています。

当レポートでは、世界のワクチンアジュバント市場について調査し、市場の概要とともに、製品タイプ別、投与ルート別、疾患タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のワクチンアジュバント市場の定義と範囲

第3章 世界のワクチンアジュバント市場力学

  • ワクチンアジュバント市場の影響分析(2019~2027年)

第4章 世界のワクチンアジュバント市場産業分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界のワクチンアジュバント市場、製品タイプ別

  • 市場スナップショット
  • 世界のワクチンアジュバント市場、製品タイプ別:パフォーマンス-潜在的な分析
  • 世界のワクチンアジュバント市場の見積と予測、製品タイプ別:2018~2027年(10億米ドル)
  • ワクチンアジュバント市場、サブセグメント分析
    • 病原体成分
    • アジュバントエマルジョン
    • 粒子状アジュバント
    • コンビネーションアジュバント
    • その他

第6章 世界のワクチンアジュバント市場、投与ルート別

  • 市場スナップショット
  • 世界のワクチンアジュバント市場、投与ルート別:パフォーマンス-潜在的な分析
  • 世界のワクチンアジュバント市場の見積と予測、投与ルート別:2018~2027年(10億米ドル)
  • ワクチンアジュバント市場、サブセグメント分析
    • 経口
    • 皮下
    • 鼻腔内
    • 筋肉内
    • 皮内
    • その他

第7章 世界のワクチンアジュバント市場、疾患タイプ別

  • 市場スナップショット
  • 世界のワクチンアジュバント市場、疾患タイプ別:パフォーマンス-潜在的な分析
  • 世界のワクチンアジュバント市場の見積と予測、疾患タイプ別:2018~2027年(10億米ドル)
  • ワクチンアジュバント市場、サブセグメント分析
    • 研究用
    • 商用

第8章 世界のワクチンアジュバント市場、用途別

  • 市場スナップショット
  • 世界のワクチンアジュバント市場、用途別:パフォーマンス-潜在的な分析
  • 世界のワクチンアジュバント市場の見積と予測、用途別:2018~2027年(10億米ドル)
  • ワクチンアジュバント市場、サブセグメント分析
    • 研究開発
    • 臨床診断

第9章 世界のワクチンアジュバント市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • SPI Pharma, Inc.
    • Brenntag Biosector A/S
    • Seppic
    • CSL Limited
    • Agenus, Inc.
    • Novavax, Inc.
    • Invivogen
    • SPI Pharma, Inc.(A Subsidiary of Associated British Foods PLC.)
    • Avanti Polar Lipids, Inc.
    • MVP Laboratories, Inc.
    • OZ Biosciences

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Vaccine Adjuvants Market, report scope
  • TABLE 2. Global Vaccine Adjuvants Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Vaccine Adjuvants Market estimates & forecasts by Product type 2018-2027 (USD Billion)
  • TABLE 4. Global Vaccine Adjuvants Market estimates & forecasts by Route of administration 2018-2027 (USD Billion)
  • TABLE 5. Global Vaccine Adjuvants Market estimates & forecasts by Disease type 2018-2027 (USD Billion)
  • TABLE 6. Global Vaccine Adjuvants Market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 7. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. U.S. Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 57. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South Korea Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 60. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 61. South KoreaVaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 63. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 64. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 66. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 67. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 69. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 70. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 72. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 73. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 75. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 76. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 77. List of secondary sources used in the study of Global Vaccine Adjuvants Market.
  • TABLE 78. List of primary sources used in the study of Global Vaccine Adjuvants Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Vaccine Adjuvants Market, research methodology
  • FIG 2. Global Vaccine Adjuvants Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Vaccine Adjuvants Market, key trends 2020
  • FIG 5. Global Vaccine Adjuvants Market, growth prospects 2021-2027
  • FIG 6. Global Vaccine Adjuvants Market, porters 5 force model
  • FIG 7. Global Vaccine Adjuvants Market, pest analysis
  • FIG 8. Global Vaccine Adjuvants Market, value chain analysis
  • FIG 9. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Vaccine Adjuvants Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Vaccine Adjuvants Market, regional snapshot 2018 & 2027
  • FIG 18. North America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Vaccine Adjuvants Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Vaccine Adjuvants Market, company market share analysis (2020)
目次

Global Vaccine Adjuvants Market is valued approximately at USD 0.70 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2021-2027. Vaccine adjuvant is an immunological agent that helps in the modification of other agents' effects. It is included in the vaccination to boost the immune response and provide long-lasting protection against the antigen. Adjuvants are added to vaccines to improve the body's response to vaccination while also reducing the number of vaccine doses given to patients. Aluminum hydroxide and paraffin oil are the most often utilized adjuvants. Vaccine adjuvant also decreases the quantity of administered foreign material. It has also been used in research and for commercial purposes. The market growth is driven by high prevalence of infectious and zoonotic diseases and increasing focus on immunization programs from various government bodies. For instance, various governmental organizations across the globe are promoting and creating awareness about vaccination against diseases such as anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other illnesses. The US government provided USD 290 million in foreign aid to the Global Alliance for Vaccines and Immunization (GAVI, now known as GAVI, the Vaccine Alliance) in 2019 and USD 226 million to the Department of Health and Human Services (HHS) to support child vaccine campaigns in other countries. However, stringent regulatory environment and time-consuming approvals may impede market growth over the forecast period of 2021-2027.

A rise in investments for R&D of novel medicines, as well as an increase in deadly epidemic illnesses, are driving the vaccine adjuvants market in the North American area. As a result, vaccination against acute and chronic illnesses is required. In addition, the existence of significant market participants in the United States increases product penetration. Adjuvance Technologies, Inc., for example, has created a portfolio of adjuvants for the treatment of a variety of diseases.

Major market player included in this report are:

SPI Pharma, Inc.

Brenntag Biosector A/S

Seppic

CSL Limited

Agenus, Inc.

Novavax, Inc.

Invivogen

SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)

Avanti Polar Lipids, Inc.

MVP Laboratories, Inc.

OZ Biosciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product type:

Pathogen Components

Adjuvant Emulsions

Particulate Adjuvants

Combination Adjuvants

Others

By Route of administration:

Oral

Subcutaneous

Intranasal

Intramuscular

Intradermal

Others

By Application:

Research Applications

Commercial Applications

By Disease type:

Infectious Diseases

Cancer

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Vaccine Adjuvants Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)
    • 1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)
    • 1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)
    • 1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vaccine Adjuvants Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vaccine Adjuvants Market Dynamics

  • 3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High prevalence of infectious and zoonotic diseases
      • 3.1.1.2. Increasing focus on immunization programs from various government bodies
    • 3.1.2. Market Restraint
      • 3.1.2.1. Stringent regulatory environment and time-consuming approvals
      • 3.1.2.2. High cost of adjuvant research
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Pandemic diseases
      • 3.1.3.2. Combination adjuvants

Chapter 4. Global Vaccine Adjuvants Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Vaccine Adjuvants Market, by Product type

  • 5.1. Market Snapshot
  • 5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis
  • 5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)
  • 5.4. Vaccine Adjuvants Market , Sub Segment Analysis
    • 5.4.1. Pathogen Components
    • 5.4.2. Adjuvant Emulsions
    • 5.4.3. Particulate Adjuvants
    • 5.4.4. Combination Adjuvants
    • 5.4.5. Others

Chapter 6. Global Vaccine Adjuvants Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)
  • 6.4. Vaccine Adjuvants Market , Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Subcutaneous
    • 6.4.3. Intranasal
    • 6.4.4. Intramuscular
    • 6.4.5. Intradermal
    • 6.4.6. Others

Chapter 7. Global Vaccine Adjuvants Market, by Disease type

  • 7.1. Market Snapshot
  • 7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis
  • 7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)
  • 7.4. Vaccine Adjuvants Market , Sub Segment Analysis
    • 7.4.1. Research Applications
    • 7.4.2. Commercial Applications

Chapter 8. Global Vaccine Adjuvants Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis
  • 8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 8.4. Vaccine Adjuvants Market , Sub Segment Analysis
    • 8.4.1. Research and Development
    • 8.4.2. Clinical Diagnostics

Chapter 9. Global Vaccine Adjuvants Market, Regional Analysis

  • 9.1. Vaccine Adjuvants Market , Regional Market Snapshot
  • 9.2. North America Vaccine Adjuvants Market
    • 9.2.1. U.S. Vaccine Adjuvants Market
      • 9.2.1.1. Product type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Disease type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. Application breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Vaccine Adjuvants Market
  • 9.3. Europe Vaccine Adjuvants Market Snapshot
    • 9.3.1. U.K. Vaccine Adjuvants Market
    • 9.3.2. Germany Vaccine Adjuvants Market
    • 9.3.3. France Vaccine Adjuvants Market
    • 9.3.4. Spain Vaccine Adjuvants Market
    • 9.3.5. Italy Vaccine Adjuvants Market
    • 9.3.6. Rest of Europe Vaccine Adjuvants Market
  • 9.4. Asia-Pacific Vaccine Adjuvants Market Snapshot
    • 9.4.1. China Vaccine Adjuvants Market
    • 9.4.2. India Vaccine Adjuvants Market
    • 9.4.3. Japan Vaccine Adjuvants Market
    • 9.4.4. Australia Vaccine Adjuvants Market
    • 9.4.5. South Korea Vaccine Adjuvants Market
    • 9.4.6. Rest of Asia Pacific Vaccine Adjuvants Market
  • 9.5. Latin America Vaccine Adjuvants Market Snapshot
    • 9.5.1. Brazil Vaccine Adjuvants Market
    • 9.5.2. Mexico Vaccine Adjuvants Market
  • 9.6. Rest of The World Vaccine Adjuvants Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. SPI Pharma, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Brenntag Biosector A/S
    • 10.2.3. Seppic
    • 10.2.4. CSL Limited
    • 10.2.5. Agenus, Inc.
    • 10.2.6. Novavax, Inc.
    • 10.2.7. Invivogen
    • 10.2.8. SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
    • 10.2.9. Avanti Polar Lipids, Inc.
    • 10.2.10. MVP Laboratories, Inc.
    • 10.2.11. OZ Biosciences

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption